| dc.contributor.author | Curtis, N | |
| dc.contributor.author | Sparrow, A | |
| dc.contributor.author | Ghebreyesus, TA | |
| dc.contributor.author | Netea, MG | |
| dc.date.accessioned | 2020-12-16T23:38:19Z | |
| dc.date.available | 2020-12-16T23:38:19Z | |
| dc.date.issued | 2020-05-16 | |
| dc.identifier | pii: S0140-6736(20)31025-4 | |
| dc.identifier.citation | Curtis, N., Sparrow, A., Ghebreyesus, T. A. & Netea, M. G. (2020). Considering BCG vaccination to reduce the impact of COVID-19. LANCET, 395 (10236), pp.1545-1546. https://doi.org/10.1016/S0140-6736(20)31025-4. | |
| dc.identifier.issn | 0140-6736 | |
| dc.identifier.uri | http://hdl.handle.net/11343/254432 | |
| dc.language | English | |
| dc.publisher | ELSEVIER SCIENCE INC | |
| dc.title | Considering BCG vaccination to reduce the impact of COVID-19 | |
| dc.type | Journal Article | |
| dc.identifier.doi | 10.1016/S0140-6736(20)31025-4 | |
| melbourne.affiliation.department | Paediatrics (RCH) | |
| melbourne.source.title | The Lancet | |
| melbourne.source.volume | 395 | |
| melbourne.source.issue | 10236 | |
| melbourne.source.pages | 1545-1546 | |
| melbourne.elementsid | 1448049 | |
| melbourne.openaccess.url | https://europepmc.org/articles/PMC7252177?pdf=render | |
| melbourne.openaccess.status | Published version | |
| melbourne.contributor.author | Curtis, Richard | |
| dc.identifier.eissn | 1474-547X | |
| melbourne.accessrights | Access this item via the Open Access location | |
